Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +751.26%
#3 ADO Protocol ADO Protocol +102.63%
#4 Cortex Cortex +94.42%
#5 Ontology Gas Ontology Gas +73.66%
#6 Kinesis Silver Kinesis Silver +54.05%
#7 OpenEden OpenEden +30.51%
#8 Magma Finance Magma Finance +24.84%
#9 QuantixAI QuantixAI +23.16%
#10 EXOD EXOD +22.78%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Flerie AB (publ) Flerie AB (publ)

Flerie AB (publ)

FLERIE
Rang in Aktien #18881
Flerie AB (publ) functions as a venture capital entity, concentrating its... Flerie AB (publ) functions as a venture capital entity, concentrating its investments on nascent businesses. The firm actively seeks to fund biotechnology and pharmaceutical companies dedicated to advancing drug discovery and development, or producing innovative tools and applications aimed at addressing pressing global health concerns. Geographically, their investment scope includes Europe, the United States, and Israel. Founded in 2011, Flerie AB (publ) is headquartered in Stockholm, Sweden, and also operates a branch office in London, United Kingdom.
Aktienkurs
$2.11
Marktkapitalisierung
$183.02M
Veränderung (1 Tag)
-1.82%
Veränderung (1 Jahr)
-45.27%
Land
SE
Handel Flerie AB (publ) (FLERIE)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Flerie AB (publ) (FLERIE)
Dividendenrendite (TTM) von Flerie AB (publ) (Aktienkürzel: FLERIE) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Flerie AB (publ) (FLERIE) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
0.57%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
2.01%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
2.74%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
2.69%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
2.47%
US